Forbase Bio

Overview

UK biotech producing enzymatic (cell-free) GMP-grade DNA to displace plasmid DNA as a critical starting material in cell and gene therapy, vaccines, and gene editing. Forbase Bio, based in the UK, manufactures enzymatic DNA at GMP grade using a cell-free manufacturing process to displace plasmid DNA as the incumbent starting material across viral vector manufacturing, mRNA therapy, gene editing, and vaccine applications. Forbase Bio holds a GMP manufacturing certificate from the UK MHRA, validating their enzymatic DNA material for clinical trial use and beyond — a regulatory milestone the company views as essential to derisk the technology for conservative pharma partners. (Segment 2 (05:00-10:00))